Newsletter

August 2019 Scorecard

The August 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

Phototronics’ Board of Directors Authorizes Share Repurchase Program

Phototronics, Inc. (PLAB) announced on August 28 that its Board of Directors authorized a stock repurchase program. The company had paused its share repurchase activity earlier in the year to focus on its investment activities. Under this program, Phototronics may repurchase up to $100 million in common stock.   Sonal sent an alert to subscribers […]

Read more...

AbbVie Receives FDA Approval for RINVOQ

On August 16, AbbVie (ABBV) announced that it received FDA approval of RINVOQ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor. The drug is expected to be available in the U.S. by the end of August 2019. RINVOQ treats adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate […]

Read more...

Perspecta Awarded Contract with National Geospatial-Intelligence Agency

On August 12, Perspecta, Inc. (PRSP) announced that it received a contract award from the National Geospatial-Intelligence Agency (NGA). It is a single award Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a maximum ceiling value of $824 million over five years. Perspecta will perform full life cycle systems engineering and integration work for the NGA. […]

Read more...